These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 4611784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Antimycotic effect of chlorotritylimidazole on Candida and Cryptococcus neoformans].
    Ritzerfeld W, Weisbrod W.
    Arzneimittelforschung; 1972 Dec; 22(12):2073-5. PubMed ID: 4575345
    [No Abstract] [Full Text] [Related]

  • 3. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract] [Full Text] [Related]

  • 4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 5. Simpotentin, a new potentiator of amphotericin B activity against Candida albicans, produced by Simplicillium minatense FKI-4981.
    Uchida R, Kondo A, Yagi A, Nonaka K, Masuma R, Kobayashi K, Tomoda H.
    J Antibiot (Tokyo); 2019 Mar; 72(3):134-140. PubMed ID: 30532035
    [Abstract] [Full Text] [Related]

  • 6. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA, Fu Y, Ibrahim AS, Mortara LA, Shafiq MC, Edwards JE, Criddle RS.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [Abstract] [Full Text] [Related]

  • 7. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Fromtling RA, Abruzzo GK, Bulmer GS.
    Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339
    [Abstract] [Full Text] [Related]

  • 8. Tipranavir exhibits different effects on opportunistic pathogenic fungi.
    Cenci E, Francisci D, Belfiori B, Pierucci S, Baldelli F, Bistoni F, Vecchiarelli A.
    J Infect; 2008 Jan; 56(1):58-64. PubMed ID: 17905438
    [Abstract] [Full Text] [Related]

  • 9. Polyoxin D inhibits growth of zoopathogenic fungi.
    Becker JM, Covert NL, Shenbagamurthi P, Steinfeld AS, Naider F.
    Antimicrob Agents Chemother; 1983 Jun; 23(6):926-9. PubMed ID: 6351734
    [Abstract] [Full Text] [Related]

  • 10. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH, Pansy F, Klepner C, Schwind R.
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V, Sauermann R, Eberl S, Zeitlinger M.
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [Abstract] [Full Text] [Related]

  • 12. Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
    Hoeprich PD, Merry JM.
    J Clin Microbiol; 1986 Aug; 24(2):269-71. PubMed ID: 3528213
    [Abstract] [Full Text] [Related]

  • 13. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS, Bartlett MS, Smith JW.
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [Abstract] [Full Text] [Related]

  • 14. The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
    de Aguiar FLL, Cavalcante CSDP, Dos Santos Fontenelle RO, Falcão CB, Andreu D, Rádis-Baptista G.
    J Appl Microbiol; 2020 Feb; 128(2):414-425. PubMed ID: 31626724
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD, Huston AC.
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [Abstract] [Full Text] [Related]

  • 16. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 17. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages.
    Nguyen LN, Lopes LC, Cordero RJ, Nosanchuk JD.
    J Antimicrob Chemother; 2011 Nov 24; 66(11):2573-80. PubMed ID: 21911344
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.
    Chitty JL, Butler MS, Suboh A, Edwards DJ, Cooper MA, Fraser JA, Robertson AAB.
    Antimicrob Agents Chemother; 2018 Feb 24; 62(2):. PubMed ID: 29158283
    [Abstract] [Full Text] [Related]

  • 19. Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B.
    Bodenhoff J.
    Acta Pathol Microbiol Scand; 1968 Feb 24; 73(4):572-82. PubMed ID: 4301525
    [No Abstract] [Full Text] [Related]

  • 20. [Ultrastructural changes in Candida albicans exposed to polyene antibiotics].
    Delektorskiĭ VV, Sheklakov ND, Golodova OA.
    Vestn Dermatol Venerol; 1980 Nov 24; (11):14-6. PubMed ID: 7003976
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.